您的位置: 首页 > 农业专利 > 详情页

METHODS FOR NOVEL DRUG DISCOVERY, TREATMENT AND SELECTIVE TARGETING FOR GEFITINIB-RESISTANT NON-SMALL-CELL LUNG CANCER HARBORING T790M MUTATION
专利权人:
MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY
发明人:
LEUNG, Elaine Lai-Han,LIU, Liang,FAN, Xing-xing
申请号:
AU2014100614
公开号:
AU2014100614A4
申请日:
2014.06.06
申请国别(地区):
AU
年份:
2014
代理人:
摘要:
#$%^&*AU2014100614A420140724.pdf#####ABSTRACT The present invention relates to methods for novel drug discovery, treatment and selective targeting for Gefitinib-resistant non-small-cell lung cancer (NSCLC) harboring an additional mutation, in particular, to the discovery of a drug candidate or agent identified by the presently claimed method for use in treating and selective targeting Gefitinib-resistant NSCLC harboring T790M mutation.CNC k~0) t cn I Cl C<;
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充